Anti-TNFs in Pregnancy Study Advises Continued Caution
FROM ANNALS OF THE RHEUMATIC DISEASES
He added: "You can’t ignore the disease, and it’s the disease itself that’s going to affect the outcome as well."
Dr. Kavanaugh, like Dr. Belmont, was not affiliated with the study.
The study investigators disclosed that the British Society for Rheumatology receives restricted income from Abbott Laboratories, Biovitrum, Shering-Plough, Wyeth Pharmaceuticals, and Roche. They added that they had no personal competing interests in relation to this study.
Dr. Kavanaugh disclosed that he has done research for the makers of TNF inhibitors, including Abbot Laboratories, Amgen, Centocor, and UCB. Dr. Belmont did not make any disclosures relevant to this study.
The British Society for Rheumatology receives funding from several pharmaceutical companies, including the makers of anti-TNFs.
